{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:28:50Z","timestamp":1786728530160,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/jcrt.jcrt_1175_16","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T05:20:40Z","timestamp":1505280040000},"page":"196-200","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients"],"prefix":"10.4103","volume":"14","author":[{"given":"Kai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20230619","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/0973-1482.200763","article-title":"Association between hepatitis B virus\/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population","volume":"12","author":"Li","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"R2-36-20230619","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0973-1482.200598","article-title":"Clinical study of transcatheter arterial chemoembolization combined with microwave ablation in the treatment of advanced hepatocellular carcinoma","volume":"12","author":"Li","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"R3-36-20230619","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000339019","article-title":"Chemoembolization in patients with hepatocellular carcinoma","volume":"1","author":"Lencioni","year":"2012","journal-title":"Liver Cancer"},{"key":"R4-36-20230619","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000343867","article-title":"How to define transarterial chemoembolization failure or refractoriness: A European perspective","volume":"3","author":"Raoul","year":"2014","journal-title":"Liver Cancer"},{"key":"R5-36-20230619","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000368142","article-title":"Transarterial chemoembolization failure\/refractoriness: JSH-LCSGJ criteria 2014 update","volume":"87","author":"Kudo","year":"2014","journal-title":"Oncology"},{"key":"R6-36-20230619","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/hep.26760","article-title":"Assessment for retreatment (ART) score for repeated transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"59","author":"Kudo","year":"2014","journal-title":"Hepatology"},{"key":"R7-36-20230619","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncr.27705","article-title":"Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma","volume":"119","author":"Lee","year":"2013","journal-title":"Cancer"},{"key":"R8-36-20230619","first-page":"381","article-title":"Transarterial Chemoemboliztion combined with sorafenib for inoperable hepatocellular carcinoma: A clinical analysis of 50 cases","volume":"5","author":"Yao","year":"2013","journal-title":"J Int Radiol"},{"key":"R9-36-20230619","first-page":"132","article-title":"The molecular and biological change of primary liver cancer treated by transartrial chemoembolization","volume":"2","author":"Xiao","year":"2008","journal-title":"Modern Med"},{"key":"R10-36-20230619","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11912-012-0233-0","article-title":"Management of hepatocellular carcinoma: Beyond sorafenib","volume":"14","author":"Chan","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"R11-36-20230619","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"R12-36-20230619","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"R13-36-20230619","doi-asserted-by":"crossref","first-page":"v59","DOI":"10.1093\/annonc\/mdq166","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Jelic","year":"2010","journal-title":"Ann Oncol"},{"key":"R14-36-20230619","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000343875","article-title":"JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the Liver Cancer Study Group of Japan","volume":"3","author":"Kudo","year":"2014","journal-title":"Liver Cancer"},{"key":"R15-36-20230619","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ajco.12438","article-title":"Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes","volume":"12","author":"Pericleous","year":"2016","journal-title":"Asia-Pac J Clin Oncol"},{"key":"R17-36-20230619","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/ajco.12272","article-title":"Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: A pilot study","volume":"11","author":"Tan","year":"2015","journal-title":"Asia-Pac J Clin Oncol"},{"key":"R18-36-20230619","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/1759-7714.12180","article-title":"Asymptomatic air-embolism following percutaneous radiofrequency ablation of lung tumor: Rare or underestimated complication?","volume":"6","author":"Rapicetta","year":"2015","journal-title":"Thoracic Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814010-00036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:28:20Z","timestamp":1786724900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814010-00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1175_16","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}